Evidence map›Paper›PMID 37917733›Full record

ArticlePLoS neglected tropical diseases2023

Phylogenomics of Leptospira santarosai, a prevalent pathogenic species in the Americas.

Diana Chinchilla, Cecilia Nieves, Ricardo Gutiérrez, Vallier Sordoillet, Frédéric J Veyrier, Mathieu Picardeau

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microorganisms · 2026
    Review
  5. Review
  6. Article
  7. Host-Driven Genetic Diversity ofTransboundary and emerging diseases · 2026
    Article
  8. Article
  9. Shaping the future ofJournal of medical microbiology · 2025
    Review
  10. Article
  11. How Is Bovine Genital Leptospirosis Diagnosed Under Field Conditions?Animals : an open access journal from MDPI · 2025
    Article
  12. Article
  13. Molecular Characterization ofTropical medicine and infectious disease · 2024
    Article
  14. Genetic structure and diversity of theLife science alliance · 2024
    Article
  15. Review
  16. Comparative genomics ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Diana ChinchillaCentro Nacional de Referencia de Bacteriología, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA), La Unión, Cartago, Costa Rica.
Cecilia NievesBacterial Symbionts Evolution, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Université du Québec, Laval, Québec, Canada.
Ricardo GutiérrezCentro Nacional de Referencia de Bacteriología, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA), La Unión, Cartago, Costa Rica.
Vallier SordoilletInstitut Pasteur, Université Paris Cité, Biology of Spirochetes Unit, Paris, France.
Frédéric J VeyrierBacterial Symbionts Evolution, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Université du Québec, Laval, Québec, Canada.
Mathieu PicardeauInstitut Pasteur, Université Paris Cité, Biology of Spirochetes Unit, Paris, France.ORCID 0000-0002-5338-5579
Institut National de la Recherche Scientifique · CAInstituto Costarricense de Investigación y Enseñanza en Nutrición y Salud · CRInstitut Pasteur · FR

Funding

Virulence and Adaptation to the Host Environment of Pathogenic LeptospiraP01AI168148 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DAVID A HAAKE · 2023 to 2026
$11.8M
NIAID NIH HHS P01 AI168148
6 · The paper itself

Abstract

backgroundLeptospirosis is a complex zoonotic disease mostly caused by a group of eight pathogenic species (L. interrogans, L. borgpetersenii, L. kirschneri, L. mayottensis, L. noguchii, L. santarosai, L. weilii, L. alexanderi), with a wide spectrum of animal reservoirs and patient outcomes. Leptospira interrogans is considered as the leading causative agent of leptospirosis worldwide and it is the most studied species. However, the genomic features and phylogeography of other Leptospira pathogenic species remain to be determined. METHODOLOGY/PRINCIPAL

findingsHere we investigated the genome diversity of the main pathogenic Leptospira species based on a collection of 914 genomes from strains isolated around the world. Genome analyses revealed species-specific genome size and GC content, and an open pangenome in the pathogenic species, except for L. mayottensis. Taking advantage of a new set of genomes of L. santarosai strains isolated from patients in Costa Rica, we took a closer look at this species. L. santarosai strains are largely distributed in America, including the Caribbean islands, with over 96% of the available genomes originating from this continent. Phylogenetic analysis showed high genetic diversity within L. santarosai, and the clonal groups identified by cgMLST were strongly associated with geographical areas. Serotype identification based on serogrouping and/or analysis of the O-antigen biosynthesis gene loci further confirmed the great diversity of strains within the species. CONCLUSIONS/SIGNIFICANCE: In conclusion, we report a comprehensive genome analysis of pathogenic Leptospira species with a focus on L. santarosai. Our study sheds new light onto the genomic diversity, evolutionary history, and epidemiology of leptospirosis in America and globally. Our findings also expand our knowledge of the genes driving O-antigen diversity. In addition, our work provides a framework for understanding the virulence and spread of L. santarosai and for improving its surveillance in both humans and animals.

Indexed as

LeptospiraLeptospirosisAnimalsHumansO AntigensPhylogenyO Antigens

Identifiers

PMID37917733
PMCPMC10645364
OpenAlexW4388214172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.